| What's new in the treatment of cocaine addiction? | |
| | |
MedLine Citation:
|
PMID: 20697850 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Cocaine dependence continues to be a significant public health problem in the United States. The number of regular cocaine users has not declined significantly in the United States since 1992. Although counseling remains the treatment of choice for cocaine dependence, many cocaine-dependent patients do not respond completely to standard drug counseling. Therefore, the development of new and more effective treatments for cocaine dependence is a research priority. Progress in the understanding of the neurobiology of cocaine dependence has led to the discovery of several promising medications that have already shown encouraging results in controlled clinical trials. Other promising compounds are just becoming available for clinical trials. The use of novel psychosocial techniques such as contingency management seems to increase the efficacy of several medications used to treat cocaine dependence. New medications and new psychosocial techniques are leading to significant improvements in the treatment of cocaine dependence. |
| | |
Authors:
|
Kyle M Kampman |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Current psychiatry reports Volume: 12 ISSN: 1535-1645 ISO Abbreviation: Curr Psychiatry Rep Publication Date: 2010 Oct |
Date Detail:
|
Created Date: 2010-09-07 Completed Date: 2011-01-03 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100888960 Medline TA: Curr Psychiatry Rep Country: United States |
Other Details:
|
Languages: eng Pagination: 441-7 Citation Subset: IM |
Affiliation:
|
Department of Psychiatry, University of Pennsylvania School of Medicine, University of Pennsylvania Treatment Research Center, Philadelphia, PA 19104, USA. kampman_k@mail.trc.upenn.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Behavior Therapy Clinical Trials as Topic Cocaine-Related Disorders / therapy* Fructose / analogs & derivatives, therapeutic use Humans United States |
| Chemical | |
Reg. No./Substance:
|
30237-26-4/Fructose; 97240-79-4/topiramate |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Attention-deficit/hyperactivity disorder in African American youth.
Next Document: Collision tumor of primary laryngeal mucosal melanoma and invasive squamous cell carcinoma with IL-1...